These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31673708)

  • 1. A Phase II Study of Neoadjuvant Stereotactic Radiosurgery for Large Brain Metastases: Clinical Trial Protocol.
    Takami H; Nassiri F; Moraes FY; Zadeh G; Bernstein M; Conrad T; Berlin A; Laperriere N; Millar BA; Shultz DB; Kongkham P
    Neurosurgery; 2020 Aug; 87(2):403-407. PubMed ID: 31673708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From Postoperative to Preoperative: A Case Series of Hypofractionated and Single-Fraction Neoadjuvant Stereotactic Radiosurgery for Brain Metastases.
    Udovicich C; Ng SP; Tange D; Bailey N; Haghighi N
    Oper Neurosurg (Hagerstown); 2022 Apr; 22(4):208-214. PubMed ID: 35234410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new treatment paradigm: neoadjuvant radiosurgery before surgical resection of brain metastases with analysis of local tumor recurrence.
    Asher AL; Burri SH; Wiggins WF; Kelly RP; Boltes MO; Mehrlich M; Norton HJ; Fraser RW
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):899-906. PubMed ID: 24606851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant Stereotactic Radiosurgery Before Surgical Resection of Cerebral Metastases.
    Patel AR; Nedzi L; Lau S; Barnett SL; Mickey BE; Moore W; Bindal S; Wardak Z; Dan T; Timmerman R; Patel TR
    World Neurosurg; 2018 Dec; 120():e480-e487. PubMed ID: 30149167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant stereotactic radiosurgery for intracerebral metastases of solid tumors (NepoMUC): a phase I dose escalation trial.
    Diehl CD; Shiban E; Straube C; Gempt J; Wilkens JJ; Oechsner M; Kessel C; Zimmer C; Wiestler B; Meyer B; Combs SE
    Cancer Commun (Lond); 2019 Nov; 39(1):73. PubMed ID: 31706337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant stereotactic radiosurgery for brain metastases: a new paradigm.
    Li YD; Coxon AT; Huang J; Abraham CD; Dowling JL; Leuthardt EC; Dunn GP; Kim AH; Dacey RG; Zipfel GJ; Evans J; Filiput EA; Chicoine MR
    Neurosurg Focus; 2022 Nov; 53(5):E8. PubMed ID: 36321291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant Stereotactic Radiosurgery: a Further Evolution in the Management of Brain Metastases.
    Udovicich C; Phillips C; Kok DL; Tange D; Plumridge NM; Prabhu RS; Haghighi N
    Curr Oncol Rep; 2019 Jul; 21(8):73. PubMed ID: 31270629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
    McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
    J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
    Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
    J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-Fraction Versus Fractionated Preoperative Radiosurgery for Resected Brain Metastases: A PROPS-BM International Multicenter Cohort Study.
    Prabhu RS; Akinyelu T; Vaslow ZK; Matsui JK; Haghighi N; Dan T; Mishra MV; Murphy ES; Boyles S; Perlow HK; Palmer JD; Udovicich C; Patel TR; Wardak Z; Woodworth GF; Ksendzovsky A; Yang K; Chao ST; Asher AL; Burri SH
    Int J Radiat Oncol Biol Phys; 2024 Mar; 118(3):650-661. PubMed ID: 37717787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase III, multicenter, randomized controlled trial of preoperative versus postoperative stereotactic radiosurgery for patients with surgically resectable brain metastases.
    Das S; Faruqi S; Nordal R; Starreveld Y; Kelly J; Bowden G; Amanie J; Fairchild A; Lim G; Loewen S; Rowe L; Wallace C; Ghosh S; Patel S
    BMC Cancer; 2022 Dec; 22(1):1368. PubMed ID: 36585629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of multi-fraction stereotactic radiosurgery for surgically resected or intact large brain metastases from non-small-cell lung cancer (NSCLC).
    Minniti G; Scaringi C; Lanzetta G; Anzellini D; Bianciardi F; Tolu B; Morace R; Romano A; Osti M; Gentile P; Paolini S
    Lung Cancer; 2019 Jun; 132():119-125. PubMed ID: 31097084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative stereotactic radiosurgery for resected brain metastases: A comparison of outcomes for large resection cavities.
    Zhong J; Ferris MJ; Switchenko J; Press RH; Buchwald Z; Olson JJ; Eaton BR; Curran WJ; Shu HG; Crocker IR; Patel KR
    Pract Radiat Oncol; 2017; 7(6):e419-e425. PubMed ID: 28668668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
    Brown PD; Ballman KV; Cerhan JH; Anderson SK; Carrero XW; Whitton AC; Greenspoon J; Parney IF; Laack NNI; Ashman JB; Bahary JP; Hadjipanayis CG; Urbanic JJ; Barker FG; Farace E; Khuntia D; Giannini C; Buckner JC; Galanis E; Roberge D
    Lancet Oncol; 2017 Aug; 18(8):1049-1060. PubMed ID: 28687377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-operative vs. post-operative stereotactic radiosurgery for operative metastatic brain tumors: study protocol for a phase III clinical trial.
    Routman DM; Jusue-Torres I; Brown PD; Trifiletti DM; Vora SA; Brown DA; Parney IF; Burns TC; Yan E
    BMC Cancer; 2024 Mar; 24(1):332. PubMed ID: 38475765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image-Guided, Linac-Based, Surgical Cavity-Hypofractionated Stereotactic Radiotherapy in 5 Daily Fractions for Brain Metastases.
    Soliman H; Myrehaug S; Tseng CL; Ruschin M; Hashmi A; Mainprize T; Spears J; Das S; Yang V; da Costa L; Maralani P; Heyn C; Atenafu EG; Sahgal A
    Neurosurgery; 2019 Nov; 85(5):E860-E869. PubMed ID: 31173150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiosurgery (SRS) to the resection cavity of brain metastases after surgical resection (SATURNUS): study protocol for a randomized phase III trial.
    Waltenberger M; Bernhardt D; Diehl C; Gempt J; Meyer B; Straube C; Wiestler B; Wilkens JJ; Zimmer C; Combs SE
    BMC Cancer; 2023 Jul; 23(1):709. PubMed ID: 37516835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing Preoperative With Postoperative Stereotactic Radiosurgery for Resectable Brain Metastases: A Multi-institutional Analysis.
    Patel KR; Burri SH; Asher AL; Crocker IR; Fraser RW; Zhang C; Chen Z; Kandula S; Zhong J; Press RH; Olson JJ; Oyesiku NM; Wait SD; Curran WJ; Shu HK; Prabhu RS
    Neurosurgery; 2016 Aug; 79(2):279-85. PubMed ID: 26528673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of neoadjuvant stereotactic radiosurgery for the treatment of brain metastases requiring surgical resection: a topic review.
    Rajkumar S; Liang Y; Wegner RE; Shepard MJ
    J Neurooncol; 2022 Dec; 160(3):691-705. PubMed ID: 36374399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.